Low Sodium Diet in Oligohydramnios Assigned for Conservative Management
Launched by WOLFSON MEDICAL CENTER · Jan 23, 2019
Trial Information
Current as of May 28, 2025
Unknown status
Keywords
ClinConnect Summary
Few studies have addressed the changes in maternal diet as affecting the composition and amount of amniotic fluid.
Some articles have shown an increase in amniotic fluid volume as a result of maternal hydration during pregnancy through intravenous fluid infusions and oral fluid intake, the increase was evident in women with amniotic fluid and women with normal amniotic fluid volume. In a mechanism similar to that of liquid hydration, a low-salt diet may lead to an increase in the volume of amniotic fluid.
The investigators would like to examine whether a low-salt diet in women with amniot...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Pregnant women between 24-37 weeks of gestation, single fetus, who were diagnosed with an amniotic fluid index at the 5th percentile or below, according to the current gestational age
- • No medical indication for immediate delivery
- Exclusion Criteria:
- • Refusal to participate in the study
- • A medical recommendation for delivery within two weeks of diagnosis
- • Fetal malformation or proof of fetal infection that known to cause oligohydramnios (eg CMV).
- • Premature rupture of membrane
- • Multiple pregnancy
- • Medical contraindication to the low-salt diet
About Wolfson Medical Center
Wolfson Medical Center is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Located in the heart of Israel, the center is equipped with state-of-the-art facilities and a multidisciplinary team of experienced healthcare professionals. Wolfson Medical Center actively engages in a wide range of clinical studies, focusing on diverse therapeutic areas, to explore new treatment modalities and enhance existing care protocols. Committed to ethical standards and patient safety, the center fosters collaboration with global research networks to contribute to the advancement of medical science and the development of effective therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
H̱olon, , Israel
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials